# clm_2441D3B433A5

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: cash_and_equivalents  
value: 7,675,000,000 United States dollar  
valid_from: 2022-03-31  
valid_to: 2022-06-30  
published: 2022-05-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_B9EFB00ADC3F  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories cash and equivalents: 7,675,000,000 United States dollar", as of 2022-03-31 (until 2022-06-30). Claim clm_2441D3B433A5, https://asof.is/claim/clm_2441D3B433A5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000110465922055285/0001104659-22-055285-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2022, filed 2022-05-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000110465922055285/0001104659-22-055285-index.htm (primary, SEC EDGAR 10-Q Q1 FY2022, published 2022-05-03)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | cash_and_equivalents | 9,799,000,000 United States dollar | valid 2021-12-31 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_2441D3B433A5](/claim/clm_2441D3B433A5.md) | [clm_26D15FF3B04A](/claim/clm_26D15FF3B04A.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
